Scientists test aggressive new attack on advanced bowel cancer
NCT ID NCT07383285
Summary
This study is testing if adding radiation to the main tumor site and two immunotherapy drugs to standard chemotherapy works better than standard chemotherapy alone for people with advanced rectal cancer that has spread. It will involve 106 participants who have a specific genetic profile (RAS mutation). The goal is to see if the more intensive treatment can better control the cancer and keep it from progressing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL NEOPLASMS MALIGNANT are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.